Trump loyalty enforcer Laura Loomer targets FDA’s Vinay Prasadnews2025-07-22T19:27:14+00:00July 22nd, 2025|Endpoints News|
Makary’s new voucher program seeks ‘most favored nation’ pricingnews2025-07-22T19:07:03+00:00July 22nd, 2025|Endpoints News|
SurGenTec® Achieves Key Milestone with Expanded Indications for OsteoFlo® HydroFiber™news2025-07-22T16:56:32+00:00July 22nd, 2025|Medical Device News Magazine|
FDA rejects Replimune’s oncolytic virus therapy for advanced melanomanews2025-07-22T12:07:52+00:00July 22nd, 2025|Endpoints News|
DualityBio Reports: Next-Generation HER3 ADC DB-1310 Granted FDA Fast Track Designationnews2025-07-22T04:27:47+00:00July 22nd, 2025|Medical Device News Magazine|
Sarepta halts US shipments of Duchenne therapy, bowing to FDAnews2025-07-22T00:33:19+00:00July 22nd, 2025|Endpoints News|
FDA threatens to use ‘full regulatory authority’ against Sareptanews2025-07-21T18:48:20+00:00July 21st, 2025|Endpoints News|
FDA’s continued approval of mRNA shots is infuriating some in MAHAnews2025-07-21T18:29:22+00:00July 21st, 2025|Endpoints News|
Endpoints livestream: What happens next with Sarepta’s Duchenne crisis? news2025-07-21T15:14:09+00:00July 21st, 2025|Endpoints News|
The FDA’s new SSRI experts have long questioned antidepressant usenews2025-07-21T10:00:41+00:00July 21st, 2025|Endpoints News|
